EcoDrugPlus

Melanocortin Receptor 4-Like

Ensembl ID : ENSFHEG00000003895
Gene Symbol: LOC105940124
3 Cross references
211 Possible Orthologues:

Melanoma Receptor Tyrosine-Protein Kinase-Like

Ensembl ID : ENSFHEG00000004380
Gene Symbol: LOC105919586
2 Cross references
212 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSFHEG00000015940
Gene Symbol: MTNR1A
3 Cross references
190 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSFHEG00000017839
Gene Symbol: MME
4 Cross references
236 Possible Orthologues:

Metabotropic Glutamate Receptor 2

Ensembl ID : ENSFHEG00000013306
Gene Symbol: LOC105933275
3 Cross references
210 Possible Orthologues:

Metabotropic Glutamate Receptor 3

Ensembl ID : ENSFHEG00000002489
Gene Symbol: LOC105939826
3 Cross references
212 Possible Orthologues:

Metabotropic Glutamate Receptor 5-Like

Ensembl ID : ENSFHEG00000018115
Gene Symbol: LOC105922713
3 Cross references
212 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSFHEG00000003182
Gene Symbol: METAP2
4 Cross references
229 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSFHEG00000009597
Gene Symbol: MAPT
2 Cross references
205 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSFHEG00000013305
Gene Symbol: MAPK1
3 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 1-Like

Ensembl ID : ENSFHEG00000019871
Gene Symbol: LOC105939894
3 Cross references
199 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSFHEG00000004109
Gene Symbol: MAPK10
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).